Present review article highlights various cardiovascular risk prediction biomarkers by
incorporating both traditional risk factors to be used as diagnostic markers and recent …

The effect and clinical benefit of P2Y12 receptor antagonists may not be limited to platelet
inhibition and the prevention of arterial thrombus formation. Potential additional effects …

The thrombosis-related diseases are one of the leading causes of illness and death in the
general population, and despite significant improvements in long-term survival due to …

(1) Background: Malondialdehyde (MDA) is a major and stable product of oxidative stress.
MDA circulates in the blood and is excreted in the urine in its free and conjugated forms …

Background High on-clopidogrel platelet reactivity could be partially explained by loss-of-
function alleles of CYP2C19, the enzyme that converts clopidogrel into its active form …

Background and aim Alzheimer's disease (AD) is a progressive neurodegenerative disease.
Multiple molecular mechanisms have been employed in its pathogenesis such as Amyloid β …

Cell surface expression of specific receptors and ecto-nucleotidases makes extracellular
nucleotides such as ATP, ADP, UTP, and adenosine suitable as signaling molecules for …

Atherosclerosis has been considered as the main cause of morbidity, mortality, and disability
worldwide. The first screening for antigen markers was conducted using the serological …

The optimal antiplatelet therapy after patent foramen ovale (PFO)/atrium septum defect
(ASD) closure is a matter of discussion. It is challenging as inter-individual responses to …

Clopidogrel (INN), an oral antiplatelet drug, has been revealed to have a number of
biological properties, for instance, anti‐inflammation and antioxidation. Oxidative stress …